Clinical trial Recruiting at 1 site Interventional Ages 18 to 99 Women only

Surgery to prevent lymphedema in breast cancer patients

Official title: Lymfo-Veneuse Anastomosen Ter Preventie Van Lymphoedeem

Run by University Hospital, Ghent · NCT05601037 · Data updated 2026-11-12

This study is testing whether a special surgery can help prevent lymphedema in breast cancer patients who are having their lymph nodes removed.

More Breast Cancer Related Lymphedema trials

Quick facts

Study typeInterventional
Ages18 Years to 99 Years
SexWomen only
Enrollment80 (estimated)
SponsorUniversity Hospital, Ghent
Academic / other
Locations1 site (Ghent, Oost-Vlaanderen)
StatusRecruiting
StartedJune 30, 2021
Main results expectedDecember 27, 2025
Study endsDecember 27, 2026
Registry record updatedNovember 8, 2024
Trial IDNCT05601037 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with breast cancer requiring axilla dissection and who have positive lymph nodes.

Probably not a fit

Patients with a history of lymphedema or a BMI greater than 35 may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of prophylactic lymphovenous anastomosis (LVA) in preventing lymphedema in patients undergoing axilla dissection for breast cancer treatment. It is a blinded randomized prospective study involving 80 patients, where one group will receive LVA during their surgery while the other group will receive standard care. Patients will be followed for two years to assess the outcomes related to lymphedema development.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of lymphedema in breast cancer patients post-surgery.

How similar studies have gone: While the concept of LVA is gaining traction, this specific approach is relatively novel and has not been extensively tested in similar studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* lymph node + breast cancer requiring dissection

Exclusion Criteria:

* previous lymphedema
* BMI \>35

Where it's running

  • Uz Gent
    Ghent, Oost-Vlaanderen, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.